What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

Thienopyridines are a class of drug targeting the platelet adenosine diphosphate 2 receptor. They have been shown to significantly reduce platelet activity exerting an important role in those clinical settings in which such an effect is beneficial. Ticlopidine was first to be introduced several year...

書誌詳細
主要な著者:	Testa, L, Bhindi, R, Van Gaal, W, Latini, R, Pizzocri, S, Lanotte, S, Biondi Zoccai, G, Valgimigli, M, Laudisa, M, Brambilla, N, Banning, A, Bedogni, F
フォーマット:	Journal article
言語:	English
出版事項:	2010

類似資料

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
著者:: Testa, L, 等
出版事項: (2010)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
著者:: L. Testa, 等
出版事項: (2010-01-01)

Use of prasugrel in patients with clopidogrel hypersensitivity
著者:: Aparna Joshi, 等
出版事項: (2022-01-01)

Interaction between statins and clopidogrel: is there anything clinically relevant?
著者:: Bhindi, R, 等
出版事項: (2008)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
著者:: Satoshi Niijima, 等
出版事項: (2018-03-01)

Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
著者:: Testa, L, 等
出版事項: (2009)

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
著者:: Dongwhane Lee, 等
出版事項: (2018-09-01)

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders
著者:: Philip M Bath, 等
出版事項: (2018-07-01)

Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis
著者:: Gerhard Selhorst, 等
出版事項: (2019-04-01)

Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis.
著者:: Testa, L, 等
出版事項: (2008)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
著者:: Jan Kiebist, 等
出版事項: (2021-09-01)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
著者:: Jim McLenachan, 等
出版事項: (2019-05-01)

In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
著者:: Muhammad Naufal Hibatullah, 等
出版事項: (2024-11-01)

Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study
著者:: Feng-Yu Kuo, 等
出版事項: (2022-09-01)

Prasugrel
著者:: Gianluca Airoldi, 等
出版事項: (2013-04-01)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
出版事項: (2019-07-01)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
著者:: Bartosz Olechowski, 等
出版事項: (2016-01-01)

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
著者:: Monica Verdoia, 等
出版事項: (2019-10-01)

Study to assess improvement in therapeutic outcomes by platelet inhibition with prasugrel
著者:: Amit Madaan
出版事項: (2015-12-01)

Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
著者:: Dongwhane Lee, 等
出版事項: (2019-03-01)

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.
著者:: Testa, L, 等
出版事項: (2008)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
著者:: Vojko Kanic, 等
出版事項: (2024-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
著者:: Yuri Kim, 等
出版事項: (2023-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention.
著者:: Yuri Kim, 等
出版事項: (2023-01-01)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
著者:: Gabriele Crimi, 等
出版事項: (2019-01-01)

Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication
著者:: Constance C. F. M. J. Baaten, 等
出版事項: (2015-09-01)

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.
著者:: Testa, L, 等
出版事項: (2009)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
著者:: Shokoufeh Hajsadeghi, 等
出版事項: (2016-01-01)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
著者:: Shokoufeh Hajsadeghi, 等
出版事項: (2016-08-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
著者:: John I. Louca, 等
出版事項: (2014-09-01)

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
著者:: P. S. LAGUTA, 等
出版事項: (2017-12-01)

Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?
著者:: Carlos G. Santos-Gallego
出版事項: (2015-09-01)

The hurdles of translating a single-center observation into practice.
著者:: Testa, L, 等
出版事項: (2008)

Digitalis: a dangerous drug in atrial fibrillation?
著者:: Testa, L, 等
出版事項: (2008)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
著者:: Lulu Dai, 等
出版事項: (2022-06-01)

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry
著者:: Goldstein P, 等
出版事項: (2016-04-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
著者:: Zhe Wang, 等
出版事項: (2020-03-01)

The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats
著者:: Christina Plante, 等
出版事項: (2024-11-01)

Sepsis favors high-on-clopidogrel platelet reactivity
著者:: Karolina Akinosoglou, 等
出版事項: (2018-01-01)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
著者:: Wiktor Kuliczkowski, 等
出版事項: (2021-01-01)